Vimta Labs [VIMTALABS] vs Sai Life Sciences [SAILIFE] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vimta Labs Ltd. wins in 12 metrics, Sai Life Sciences Ltd. wins in 6 metrics, with 0 ties. Vimta Labs Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vimta Labs Ltd. | Sai Life Sciences Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.76 | 64.75 | Vimta Labs Ltd. |
| Price-to-Book Ratio | 5.13 | 9.48 | Vimta Labs Ltd. |
| Debt-to-Equity Ratio | 1.63 | 18.40 | Vimta Labs Ltd. |
| PEG Ratio | -1.60 | 51.15 | Sai Life Sciences Ltd. |
| EV/EBITDA | 15.59 | 39.40 | Vimta Labs Ltd. |
| Profit Margin (TTM) | 18.82% | 15.34% | Vimta Labs Ltd. |
| Operating Margin (TTM) | 23.64% | 25.84% | Sai Life Sciences Ltd. |
| EBITDA Margin (TTM) | 23.64% | 25.84% | Sai Life Sciences Ltd. |
| Return on Equity | 17.78% | 7.99% | Vimta Labs Ltd. |
| Return on Assets (TTM) | 14.43% | 5.38% | Vimta Labs Ltd. |
| Free Cash Flow (TTM) | $151.19M | $-552.35M | Vimta Labs Ltd. |
| Dividend Yield | 0.83% | N/A | N/A |
| 1-Year Return | -4.01% | 53.25% | Sai Life Sciences Ltd. |
| Price-to-Sales Ratio (TTM) | 5.44 | 10.00 | Vimta Labs Ltd. |
| Enterprise Value | $20.76B | $219.67B | Sai Life Sciences Ltd. |
| EV/Revenue Ratio | 5.27 | 10.12 | Vimta Labs Ltd. |
| Gross Profit Margin (TTM) | 80.37% | 45.92% | Vimta Labs Ltd. |
| Revenue per Share (TTM) | $88 | $103 | Sai Life Sciences Ltd. |
| Earnings per Share (Diluted) | $16.63 | $15.83 | Vimta Labs Ltd. |
| Beta (Stock Volatility) | -0.28 | N/A | N/A |
Vimta Labs Ltd. vs Sai Life Sciences Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vimta Labs Ltd. | 9.27% | 1.59% | -1.41% | 6.88% | -22.29% | -21.91% |
| Sai Life Sciences Ltd. | 0.83% | -1.11% | 4.31% | 13.24% | 28.59% | 25.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vimta Labs Ltd. | -4.01% | 127.88% | 285.95% | 1,215.69% | 2,521.09% | 343.62% |
| Sai Life Sciences Ltd. | 53.25% | 64.85% | 64.85% | 64.85% | 64.85% | 64.85% |
Performance & Financial Health Analysis: Vimta Labs Ltd. vs Sai Life Sciences Ltd.
| Metric | VIMTALABS | SAILIFE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹20.49B | ₹217.06B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 185,213 | 509,735 |
| 90 Day Avg. Volume | 174,604 | 545,743 |
| Last Close | ₹513.25 | ₹1,137.70 |
| 52 Week Range | ₹376.05 - ₹902.65 | ₹716.60 - ₹1,184.80 |
| % from 52W High | -43.14% | -3.98% |
| All-Time High | ₹1,178.00 (Feb 10, 2025) | ₹1,184.80 (May 25, 2026) |
| % from All-Time High | -56.43% | -3.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.27% |
| Quarterly Earnings Growth | -0.18% | 0.86% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.15% |
| Operating Margin (TTM) | 0.24% | 0.26% |
| Return on Equity (TTM) | 0.18% | 0.08% |
| Debt to Equity (MRQ) | 1.63 | 18.40 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹93.23 | ₹108.17 |
| Cash per Share (MRQ) | ₹12.28 | ₹14.59 |
| Operating Cash Flow (TTM) | ₹812.55M | ₹518.10M |
| Levered Free Cash Flow (TTM) | ₹673.42M | ₹1.70B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.83% | N/A |
| Last 12-Month Dividend | ₹4.00 | N/A |
Valuation & Enterprise Metrics Analysis: Vimta Labs Ltd. vs Sai Life Sciences Ltd.
| Metric | VIMTALABS (Apr 24, 2026) | SAILIFE (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.76 | 64.75 |
| Forward P/E | N/A | 51.15 |
| PEG Ratio | -1.60 | 51.15 |
| Price to Sales (TTM) | 5.44 | 10.00 |
| Price to Book (MRQ) | 5.13 | 9.48 |
| Market Capitalization | ||
| Market Capitalization | ₹20.49B | ₹217.06B |
| Enterprise Value | ₹20.76B | ₹219.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.27 | 10.12 |
| Enterprise to EBITDA | 15.59 | 39.40 |
| Risk & Other Metrics | ||
| Beta | -0.28 | N/A |
| Book Value per Share (MRQ) | ₹93.23 | ₹108.17 |
Financial Statements Comparison: Vimta Labs Ltd. vs Sai Life Sciences Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | VIMTALABS (2025) | SAILIFE (2025) |
|---|---|---|
| Revenue/Sales | 3.44B | 16.60B |
| Cost of Goods Sold | 714.47M | 10.41B |
| COGS % of Revenue | 20.8% | 62.7% |
| Gross Profit | 2.73B | 6.19B |
| Gross Margin | 79.2% | 37.3% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 906.01M | 2.73B |
| Operating Margin | 26.3% | 16.5% |
| EBITDA | 1.29B | 4.46B |
| EBITDA Margin | 37.6% | 26.9% |
| Pre-Tax Income | 890.00M | 2.28B |
| Pre-Tax Income % of Revenue | 25.9% | 13.7% |
| Income Tax | 222.45M | 575.71M |
| Income Tax % of Revenue | 6.5% | 3.5% |
| Net Income (Profit) | 673.42M | 1.70B |
| Profit Margin | 19.6% | 10.2% |
Balance Sheet & Liquidity Metrics
| Metric | VIMTALABS (2025) | SAILIFE (2025) |
|---|---|---|
| Cash & Equivalents | 158.36M | 911.19M |
| Total Current Assets | 1.88B | 15.05B |
| Total Current Assets % of Revenue | 54.6% | 90.6% |
| Total Current Liabilities | 643.67M | 7.32B |
| Total Current Liabilities % of Revenue | 18.7% | 44.1% |
| Long-Term Debt | 32.24M | 1.65B |
| Long-Term Debt % of Revenue | 0.9% | 9.9% |
| Total Shareholders Equity | 3.79B | 21.28B |
| Retained Earnings | 2.80B | 7.24B |
| Retained Earnings % of Revenue | 81.4% | 43.6% |
| Property, Plant & Equipment | 89.36M | 1.51B |
Cash Flow Statement Comparison
| Metric | VIMTALABS (2025) | SAILIFE (2025) |
|---|---|---|
| Operating Cash Flow | 812.55M | 518.10M |
| Operating Cash Flow % of Revenue | 23.6% | 3.1% |
| Capital Expenditures | -761.90M | -3.69B |
| Free Cash Flow | 151.19M | -552.35M |
| FCF Margin | 4.4% | -3.3% |
| Debt Repayment | -116.50M | -3.90B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VIMTALABS | SAILIFE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 44.67M | 211.78M |
| Float Shares | 15.14M | 88.67M |
| % Held by Insiders | 65.84% | 38.09% |
| % Held by Institutions | 4.16% | 44.22% |
| % Held by Public | 30.00% | 17.69% |
Dividend Analysis & Yield Comparison: Vimta Labs Ltd. vs Sai Life Sciences Ltd.
| Metric | VIMTALABS | SAILIFE |
|---|---|---|
| Last 12-Month Dividend | ₹4.00 | N/A |
| Last 12-Month Dividend Yield | 0.83% | N/A |
| 3-Year Avg Annual Dividend | ₹2.00 | N/A |
| 3-Year Avg Dividend Yield | 0.44% | N/A |
| 3-Year Total Dividends | ₹6.00 | N/A |
| Ex-Dividend Date | May 30, 2025 | N/A |